HK1083761A1 - Pyridylsulfonamido pyrimidines for treating diabetic nephropathy - Google Patents

Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Info

Publication number
HK1083761A1
HK1083761A1 HK06103985A HK06103985A HK1083761A1 HK 1083761 A1 HK1083761 A1 HK 1083761A1 HK 06103985 A HK06103985 A HK 06103985A HK 06103985 A HK06103985 A HK 06103985A HK 1083761 A1 HK1083761 A1 HK 1083761A1
Authority
HK
Hong Kong
Prior art keywords
diabetic nephropathy
pyridylsulfonamido
pyrimidines
treating diabetic
zero
Prior art date
Application number
HK06103985A
Other languages
English (en)
Inventor
Jessica Mann
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Publication of HK1083761A1 publication Critical patent/HK1083761A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK06103985A 2003-03-06 2006-03-30 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy HK1083761A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100549A EP1454625A1 (fr) 2003-03-06 2003-03-06 Pyridylsulfonamidyl-pyrimidines pour le traitement des néphropaties diabétiques
PCT/EP2004/050242 WO2004078104A2 (fr) 2003-03-06 2004-03-03 Nouveau medicament

Publications (1)

Publication Number Publication Date
HK1083761A1 true HK1083761A1 (en) 2006-07-14

Family

ID=32799012

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06103985A HK1083761A1 (en) 2003-03-06 2006-03-30 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Country Status (27)

Country Link
US (2) US20060094731A1 (fr)
EP (2) EP1454625A1 (fr)
JP (1) JP4737686B2 (fr)
KR (1) KR101099189B1 (fr)
CN (1) CN100453081C (fr)
AT (1) ATE395063T1 (fr)
AU (2) AU2004216858B2 (fr)
BR (1) BRPI0408082A (fr)
CA (1) CA2517930C (fr)
CY (1) CY1108241T1 (fr)
DE (1) DE602004013734D1 (fr)
DK (1) DK1601361T3 (fr)
EC (1) ECSP056060A (fr)
ES (1) ES2305737T3 (fr)
HK (1) HK1083761A1 (fr)
HR (1) HRP20050860A2 (fr)
IL (1) IL170626A (fr)
MX (1) MXPA05009478A (fr)
NO (1) NO20054148L (fr)
NZ (1) NZ542155A (fr)
PL (1) PL1601361T3 (fr)
PT (1) PT1601361E (fr)
RS (1) RS20050683A (fr)
SI (1) SI1601361T1 (fr)
UA (1) UA82087C2 (fr)
WO (1) WO2004078104A2 (fr)
ZA (1) ZA200507122B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595880A1 (fr) * 2004-05-13 2005-11-16 Speedel Pharma AG Formes crystallines d'un pyridinylsulphonamide et leur utilisation comme antagonistes du récepteur de l'endothéline
BRPI0615794A2 (pt) * 2005-09-12 2011-05-24 Speedel Pharma Ag piridilsulfonamidil-pirimidinas para a prevenção de falha de enxerto de vaso sangüìneo
CN102933233A (zh) 2010-06-17 2013-02-13 日东电工株式会社 肾纤维化处理剂
CN109260164A (zh) * 2018-10-07 2019-01-25 威海贯标信息科技有限公司 一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK117996A3 (en) * 1994-03-17 1997-03-05 Ciba Geigy Ag Pharmaceutical composition for treatment of diabetic nephropathy
CA2162630C (fr) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
JPH11513022A (ja) * 1995-08-02 1999-11-09 スミスクライン・ビーチャム・コーポレイション エンドセリンレセプターアンタゴニスト
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
WO2001081335A1 (fr) * 2000-04-20 2001-11-01 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides agissant comme antagonistes de l'endotheline

Also Published As

Publication number Publication date
CA2517930C (fr) 2011-04-26
KR20050106083A (ko) 2005-11-08
JP4737686B2 (ja) 2011-08-03
EP1601361A2 (fr) 2005-12-07
CN1756552A (zh) 2006-04-05
AU2004216858B2 (en) 2009-07-16
US20060094731A1 (en) 2006-05-04
US20090005404A1 (en) 2009-01-01
DK1601361T3 (da) 2008-08-25
KR101099189B1 (ko) 2011-12-27
NZ542155A (en) 2008-09-26
RS20050683A (en) 2007-11-15
EP1454625A1 (fr) 2004-09-08
CA2517930A1 (fr) 2004-09-16
ATE395063T1 (de) 2008-05-15
ECSP056060A (es) 2006-01-27
MXPA05009478A (es) 2005-10-18
PL1601361T3 (pl) 2008-10-31
CY1108241T1 (el) 2013-09-04
CN100453081C (zh) 2009-01-21
IL170626A (en) 2010-05-31
EP1601361B1 (fr) 2008-05-14
DE602004013734D1 (de) 2008-06-26
AU2009225323B2 (en) 2011-11-24
WO2004078104A3 (fr) 2004-10-28
BRPI0408082A (pt) 2006-02-14
ZA200507122B (en) 2006-05-31
AU2004216858A1 (en) 2004-09-16
PT1601361E (pt) 2008-07-29
JP2006519817A (ja) 2006-08-31
AU2009225323A1 (en) 2009-11-05
HRP20050860A2 (en) 2005-10-31
SI1601361T1 (sl) 2008-10-31
NO20054148L (no) 2005-09-06
UA82087C2 (uk) 2008-03-11
ES2305737T3 (es) 2008-11-01
WO2004078104A2 (fr) 2004-09-16

Similar Documents

Publication Publication Date Title
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
WO2008079339A3 (fr) Composés de tétracycline substituée
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
TW200505919A (en) DPP-IV inhibitors
GB0226930D0 (en) Chemical compounds
HK1121440A1 (en) Biphenyl derivatives and their use in treating hepatitis c
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
BR0314059A (pt) Compostos heterocìclicos
DE602004018630D1 (en) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
MXPA04007391A (es) Heterociclos triciclicos fusionados utiles para el tratamiento de padecimientos hiper-proliferantes.
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
HK1083761A1 (en) Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
GB0412314D0 (en) Compounds
TW200609228A (en) Substituted n-acyl-2-aminothiazoles
DE60204611D1 (de) Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
ZA200800999B (en) Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
TW200603800A (en) 4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof
DK1499312T3 (da) Anvendelse af hydroxypyridonderivater til sårheling
DK1421086T3 (da) 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet
UA96296C2 (en) Pyridazine compounds and use thereof
TW200519071A (en) 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
ATE338759T1 (de) 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130303